Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 26, 2019
Metabolism and Lung Toxicity of Inhaled Naphthalene: Effects of Postnatal Age and SexSarah A Carratt, Nataliia Kovalchuk, Xinxin Ding, et al.Biomarker Research|January 31, 2021
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case reportSarah A Carratt, Diana Brewer, Julia E Maxson, et al.Regulatory Toxicology and Pharmacology : RTP|August 10, 2020
Comparison of acute respiratory epithelial toxicity for 4-Methylimidazole and naphthalene administered by oral gavage in B6C3F1 miceJacklyn S Kelty, Chayoung Keum, Veneese J Brown, et al.Nuclear Instruments & Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms|January 12, 2019
Naphthalene DNA Adduct Formation and Tolerance in the LungBruce A Buchholz, Sarah A Carratt, Edward A Kuhn, et al.Nanoscale|May 21, 2016
Novel multi-functional europium-doped gadolinium oxide nanoparticle aerosols facilitate the study of deposition in the developing rat lungGautom K Das, Donald S Anderson, Chris D Wallis, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 19, 2024
An industry perspective on the FDA Modernization Act 2.0/3.0: potential next steps for sponsors to reduce animal use in drug developmentSarah A Carratt, Christina L Zuch de Zafra, Elias Oziolor, et al.Toxicology Letters|January 27, 2019
Naphthalene genotoxicity: DNA adducts in primate and mouse airway explantsSarah A Carratt, Matthew Hartog, Bruce A Buchholz, et al.Leukemia|May 18, 2021
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSarah A Carratt, Theodore P Braun, Cody Coblentz, et al.Chemical Research in Toxicology|February 23, 2026
Naphthalene-DNA Adduct Formation in a Lung Airway Explant Model: The Role of Bioactivation and Naphthalene MetabolitesMorgan C Domanico, Sarah A Carratt, Nicole Collette, et al.Proceedings of the National Academy of Sciences of the United States of America|May 31, 2020
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemiaTheodore P Braun, Cody Coblentz, Brittany M Curtiss, et al.Pageof 2